A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma

Trial Identifier: D8315C00001
Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd.
Start Date: December 2023
Primary Completion Date: March 2026
Study Completion Date: June 2026
Condition: Myeloma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Shanghai Shanghai, China, 200003
China, Zhejiang Hangzhou, Zhejiang, China, 310003
CN Beijing, CN, 102200
CN Beijing, CN, 100024
CN Hangzhou, CN, 310003
CN Jinan, CN, 250117
CN Shanghai, CN, 201210
CN Shanghai, CN, 200003
CN Shenyang, CN, 110134
CN Wenzhou, CN, 325000
CN Wuhan, CN, 430030
CN XI'AN, CN, 710004